Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
International Journal of Medicinal Mushrooms
IF: 1.423 5-Year IF: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN Print: 1521-9437
ISSN Online: 1940-4344

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v18.i1.10
pages 1-7

Effect of the Medicinal Mushroom, Grifola gargal (Agaricomycetes), on Bone Turnover Markers and Serum Lipids in Middle-Aged and Elderly Japanese Women

Etsuko Harada
Department of Immunology, Mie University School of Medicine
Toshihiro Morizono
Iwade Research Institute of Mycology Co. Ltd., Mie, Japan
Toshimitsu Sumiya
Iwade Research Institute of Mycology Co. Ltd., Mie, Japan
Hirokazu Kawagishi
Research Institute of Green Science and Technology, Shizuoka University, Shizuoka, Japan; Graduate School of Agriculture, Shizuoka University, Shizuoka, Japan; and Graduate School of Science and Technology, Shizuoka University, Japan

ABSTRACT

A clinical study was performed to examine the effect of the edible mushroom, Grifola gargal, on bone turnover markers and serum lipids in middle-aged and elderly Japanese women. Postmenopausal women aged 51−73 years (mean age, 61 years) received daily oral administration of 5 g G. gargal fruiting bodies (hot air-dried and powdered; G. gargal powder [GGP]). Serum levels of bone alkaline phosphatase (BAP) and lipids and urinary deoxypyridinoline (DPD) levels were measured before and 2 weeks after the start of GGP treatment. As a result, urinary DPD bone resorption marker levels in women treated with GGP decreased significantly. Serum levels of the BAP bone formation marker also tended to increase, but the difference was not significant. By contrast, the atherogenic index decreased and the high-density lipoprotein (HDL) ratio increased significantly. However, there were no statistically significant differences in serum lipids of total cholesterol, HDL cholesterol, and low-density lipoprotein cholesterol. In addition, this study demonstrated for the first time that G. gargal is safe for human consumption.


Articles with similar content:

The Effects of the King Oyster Mushroom Pleurotus eryngii (Higher Basidiomycetes) on Glycemic Control in Alloxan-Induced Diabetic Mice
International Journal of Medicinal Mushrooms, Vol.16, 2014, issue 3
Huan Zhan, Ya-li Lei, Jian-Ping Li
Hepato- and Nephroprotective Activities of a Nigerian Local King Tuber Oyster Mushroom, Pleurotus tuberregium (Higher Basidiomycetes), in Chemically Induced Organ Toxicities in Rats
International Journal of Medicinal Mushrooms, Vol.16, 2014, issue 4
Stella A. Ihim, Kolawole A. Laiyemo, Chukwuemeka Sylvester Nworu, Peter A. Akah, Loveth E. Ugwu
Protective Effects of Extract from Sclerotium of the King Tuber Medicinal Mushroom, Pleurotus tuberregium (Higher Basidiomycetes) on Carbon Tetrachloride-Induced Hepatotoxicity in Wistar Albino Rats
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 12
Christopher C. Osubor, Chidube A. Alagbaoso, Omoanghe S. Isikhuemhen
Protection against Gut Inflammation and Sepsis in Mice by the Autodigested Product of the Lingzhi Medicinal Mushroom, Ganoderma lingzhi (Agaricomycetes)
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 9
Yoshiyuki Adachi, Daisuke Yamanaka, Toshitsugu Miyazaki, Hisatomi Ito, Yuina Ishimoto, Kentaro Igami, Naohito Ohno, Ken-Ichi Ishibashi
Hepatoprotective Effects of Aqueous Extract from Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Higher Basidiomycetes) on α-Amanitin−Induced Liver Injury in Mice
International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 4
Jinsong Hu, Xin Wu, Jun Zeng, Qiong Liao, Zuohong Chen, Rong Zhou, Ping Zhang